Intravenous bisphosphonates for postmenopausal osteoporosis
Numerous clinical studies have shown bisphoshonates (BPs) to be useful and cost-effective options for the fractures prevention and postmenopausal bone loss. The use of oral bisphoshonates is an established option for managment of osteoporosis in postmenopausal women, but many of them complaint from...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medknow Publications
2010
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082804/ |